Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1999
11/11/1999CA2650642A1 Neisseria meningitidis antigens and compositions
11/11/1999CA2331844A1 A method for diagnosing and treating chronic pelvic pain syndrome
11/11/1999CA2331738A1 Oral administration of immunoglobulins for treating autoimmune hearing loss
11/11/1999CA2330838A1 Neisseria meningitidis antigens and compositions
11/11/1999CA2330814A1 Bacteriophage assay
11/11/1999CA2330610A1 Adjuvant composition and methods for its use
11/11/1999CA2328602A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
11/11/1999CA2328495A1 Vaccine for pseudomonas aeruginosa
11/11/1999CA2328132A1 Growth-associated protease inhibitor heavy chain precursor
11/11/1999CA2328108A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999CA2328059A1 Use of interleukin-18 as vaccine adjuvant
11/11/1999CA2327584A1 Attenuated influenza viruses
11/11/1999CA2327539A1 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
11/11/1999CA2327530A1 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999CA2327355A1 Human receptor molecules
11/11/1999CA2327316A1 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
11/11/1999CA2327262A1 Methods of raising animals for meat production
11/11/1999CA2326671A1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999CA2326402A1 Preparation of human papillomavirus e1 having helicase activity and method therefor
11/11/1999CA2324650A1 Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate
11/11/1999CA2295323A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999CA2248963A1 Novel compounds
11/10/1999EP0955545A1 Process to select bacterial strains
11/10/1999EP0955366A1 Antigenic protein originating in malassezia
11/10/1999EP0955361A1 Monoclonal antibodies to tumor-associated antigens, methods for their production, and their use
11/10/1999EP0955311A2 Peptide vaccine for canine allergy
11/10/1999EP0955061A1 Oral product for the prevention and therapy of porcine gastroenteric infections
11/10/1999EP0955060A1 Remedies for acute pulmonary injuries due to indirect causes containing anti-il-8 antibody as the active ingredient
11/10/1999EP0955059A2 Vaccines containing a saponin and a sterol
11/10/1999EP0954978A1 New products comprising inactivated yeasts or moulds provided with active antibodies
11/10/1999EP0954605A1 Method and probes for the identification of microbial genes specifically induced during host infection
11/10/1999EP0954602A1 Hereditary hemochromatosis gene
11/10/1999EP0954593A1 Recombinant pox virus for immunization against tumor-associated antigens
11/10/1999EP0954585A2 Human telomerase catalytic subunit
11/10/1999EP0954582A1 Polynucleotide vaccine against canine distemper
11/10/1999EP0954573A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
11/10/1999EP0954564A1 Methods for generating cytotoxic t cells in vitro
11/10/1999EP0954537A2 Chitosan-conjugates with acidic chelate-complex forming agents
11/10/1999EP0954535A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
11/10/1999EP0954534A1 Pasteurization of immunoglobulin solutions
11/10/1999EP0954531A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
11/10/1999EP0954530A1 Immunomodulatory peptides of vespid antigen 5
11/10/1999EP0954529A1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
11/10/1999EP0954525A1 Novel compounds
11/10/1999EP0954340A1 Targeted combination immunotherapy of cancer
11/10/1999EP0954334A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
11/10/1999EP0954333A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/10/1999EP0954332A1 Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases
11/10/1999EP0954331A1 Novel compounds
11/10/1999EP0954329A1 Method of killing target cells in harvested cell populations with one or more immunotoxins
11/10/1999EP0954324A1 Cyclic peptide vaccines for treatment and prevention of diabetes
11/10/1999EP0954286A2 Liposomal influenza vaccine composition and method
11/10/1999EP0954223A1 Modified live avian polyomavirus vaccine in psittacine birds
11/10/1999EP0765333B1 Quillaja saponin adjuvant and vaccine formulation containing same
11/10/1999EP0724588B1 Drug binding protein
11/10/1999CN1234806A G protein-coupled receptor antagonists
11/10/1999CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same
11/10/1999CN1234441A Recombined pure herpes virus built by using adhesive particles as basis and use thereof
11/10/1999CN1234406A Single-chain multiple antigen-binding molecule, its preparation and use
11/10/1999CN1234405A High-effective broad-spectrum antibody for inhibiting growth and metastasis of tumour
11/10/1999CN1234276A Process for producing transfer factors resisting virus of respiratory tract
11/10/1999CN1046314C Monoclonal antibody with characteristics of causing programmatic death of cells
11/10/1999CN1046291C Protein Rib, process for purification of the protein, reagent kit and pharmaceutical composition
11/09/1999US5981712 Antibody which binds to carboxyamido-triazole resistance protein; for detecting resistance to drug which prevents calcium influx in biological samples/cells
11/09/1999US5981711 Antibodies which bind to protein from putative oncogene; for probes and imaging agents used in diagnosis/prognosis of cancer/tumors; anticarcinogenic/antitumor agents and vaccines
11/09/1999US5981708 Rodent polypeptide which is an autocrine growth factor; for augmenting growth of hematopoeitic stem cells; for antitumor agents to control tumor cell growth
11/09/1999US5981707 Nucleotide and amino acid sequences of protein which binds to telomerase rna; for investigating aging and proliferation; antiproliferative agents
11/09/1999US5981697 Synthetic peptides, antibodies against them and their use
11/09/1999US5981505 Compositions and methods for delivery of genetic material
11/09/1999US5981503 Analog of Haemophilus Hin47 with reduced protease activity
11/09/1999US5981299 Method of producing antibodies to an enzyme; immunizing cows with purified enzymes, recovering milk from cows, purifying antibodies; to alter the cholesterol composition of food; dietetics
11/09/1999US5981277 Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/09/1999US5981276 Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
11/09/1999US5981252 Enzyme for diagnosis of atherosclerosis; for screening enzyme inhibitors as therapy
11/09/1999US5981246 Nucleic acids encoding EPH-like receptor protein tyrosine kinases
11/09/1999US5981245 Polypeptide kinase coded by a nucleic acid sequence; antibody development; for modulating kinase receptor activation and detecting receptor ligands
11/09/1999US5981229 For passive immune therapy; for diagnosis and prevention of grampositive bacterial infection; for prevention of infection by antibiotic resistant microoganisms
11/09/1999US5981228 Mammalian ZPAs
11/09/1999US5981224 Bovine heat shock promoter and uses thereof
11/09/1999US5981220 Nucleotide sequences coding protein associated with skin differentiation; diagnostic assays for detecting bone and skin disorders; treatment of osteoporosis, bone fractures
11/09/1999US5981213 Dna sequence coding microorganism outer membrane protein; detect the presence of antigens and/or antibodies in a sample; vaccine development
11/09/1999US5981205 Nuclear Dbf2- related (Ndr) kinases
11/09/1999US5981173 Human urogenital virus dna; for diagnosis and for developing models for cancer of urogenital system
11/09/1999US5981172 Probe for viral untranslated region; detecting viral nucleic acids; deveolping vaccines and antibodies to use as diagnostic tool in detecting presence of virus
11/09/1999US5981170 Diagnostic immunoassay kit for detection of antibodies induced by human immunodeficiency virus in sample of body fluid; includes artificial peptide of an epitope having a cystine bridge
11/09/1999US5980913 A tetrapeptides as vaccine adjuvant
11/09/1999US5980912 Chitosan induced immunopotentiation
11/09/1999US5980911 Enhancing an immune synergy response to an antigen comprising the administration of at least two cytokines
11/09/1999US5980910 Useful in coating polymeric medical materials to prevent colonization by coagulase-negative staphylococcal strains, in assays for the detection of such bacteria
11/09/1999US5980909 Epitopic regions of pneumococcal surface protein A
11/09/1999US5980908 A vaccine comprising an isolated fibronectin binding protein derived from staphylococcus aureus, by forming antibodies against the staphylococcus aureus bacterial strain
11/09/1999US5980907 Use in immunoprophylaxis
11/09/1999US5980906 Live recombinant avian vaccine using an avian herpesvirus as vector
11/09/1999US5980901 Viral defective interfering particles and uses thereof
11/09/1999US5980900 Amino acid DNA sequences related to genomic RNA of human immunodeficiency virus (HIV-1)
11/09/1999US5980899 Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells
11/09/1999US5980898 Adjuvant for transcutaneous immunization
11/09/1999US5980895 Immunotoxin containing a disulfide-stabilized antibody fragment joined to a Pseudomonas exotoxin that does not require proteolytic activation
11/09/1999US5980892 Increasing cytotoxicity by exposing t lymphocytes to a monoclonal antibody, reacting with an epitope of the variable region of a t cell antigen receptor; treating rheumatoid arthritis
11/09/1999CA1340817C Recombinant flagellin vaccines
1 ... 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 ... 1823